A critically ill client with septic shock has a triple-lumen central venous catheter (CVC) inserted in the right internal jugular vein. The client is receiving a continuous intravenous infusion of norepinephrine through the proximal lumen and a continuous intravenous infusion of propofol through the distal lumen. The medial lumen is currently saline-locked. The healthcare provider prescribes an intermittent intravenous piggyback (IVPB) dose of pantoprazole. The nurse verifies in an intravenous drug reference guide that pantoprazole is physically incompatible at the Y-site with both norepinephrine and propofol. What is the most appropriate nursing action?
- Administer the pantoprazole dose through the medial lumen of the existing central venous catheter.Answer
- BPause the norepinephrine infusion, flush the proximal lumen, administer the pantoprazole, and resume the norepinephrine.
- CInsert a new peripheral intravenous catheter to administer the pantoprazole independently.
- DWithhold the pantoprazole dose until the client's condition improves and the norepinephrine is discontinued.
Answer
The most appropriate action is to administer the pantoprazole through the dedicated medial lumen of the existing central venous catheter.
A multi-lumen central venous catheter (CVC) consists of separate, independent internal channels that exit at staggered points (typically designated as proximal, medial, and distal) along the distal tip of the catheter. Because these lumens are physically separated from one another, medications administered through different lumens do not mix within the catheter tubing itself. Once the fluids exit their respective catheter ports, the rapid and high-volume blood flow in the central vein (such as the superior vena cava) immediately dilutes them. Therefore, it is clinically safe and considered standard nursing practice to administer Y-site incompatible medications concurrently through separate lumens of the same multi-lumen CVC.
Step-by-Step Solution
Key Concept
Multi-lumen central venous catheters contain physically separated internal channels, allowing the safe, simultaneous administration of Y-site incompatible medications without the need for additional vascular access.